{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:59:01Z","timestamp":1793948341158,"version":"4.8.0"},"reference-count":202,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04821-4","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T13:13:28Z","timestamp":1785590008000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Harnessing chitosan-based biomaterials for advanced cancer immunotherapy: from nanocarriers to tumor microenvironment modulation"],"prefix":"10.1186","volume":"24","author":[{"given":"Yun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qasim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haishan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"4821_CR1","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.jconrel.2022.07.036","volume":"349","author":"F Davodabadi","year":"2022","unstructured":"Davodabadi F, SarYun Wang M, Arabpour J, Sargazi S, Rahdar A, D\u00edez-Pascual AM. Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches. J Control Release. 2022;349:844\u201375.","journal-title":"J Control Release"},{"issue":"10","key":"4821_CR2","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1080\/1061186X.2025.2528921","volume":"33","author":"N Jabarimani","year":"2025","unstructured":"Jabarimani N, Khabazian E, Morshedi B, et al. Boosting breast cancer immunotherapy through targeted siRNA delivery and sequential chemotherapy. J Drug Target. 2025;33(10):1902\u201313.","journal-title":"J Drug Target"},{"key":"4821_CR3","doi-asserted-by":"publisher","first-page":"150958","DOI":"10.1016\/j.ijbiomac.2026.150958","volume":"350","author":"S Salehi","year":"2026","unstructured":"Salehi S, Naghib SM. Emerging trends and future directions in microfluidic-assisted chitosan-based hydrogel nanoparticles for cancer immunotherapy: A review. Int J Biol Macromol. 2026;350:150958.","journal-title":"Int J Biol Macromol"},{"key":"4821_CR4","first-page":"358","volume":"28","author":"S Song","year":"2023","unstructured":"Song S, Shim MK, Yang S, et al. All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy. Bioact Mater. 2023;28:358\u201375.","journal-title":"Bioact Mater"},{"issue":"15","key":"4821_CR5","doi-asserted-by":"publisher","first-page":"e2309591","DOI":"10.1002\/adma.202309591","volume":"36","author":"H Wang","year":"2024","unstructured":"Wang H, Chen Y, Wei R, et al. Synergistic Chemoimmunotherapy Augmentation via Sequential Nanocomposite Hydrogel-Mediated Reprogramming of Cancer-Associated Fibroblasts in Osteosarcoma. Adv Mater. 2024;36(15):e2309591.","journal-title":"Adv Mater"},{"issue":"12","key":"4821_CR6","doi-asserted-by":"publisher","first-page":"11817","DOI":"10.1021\/acsnano.3c02985","volume":"17","author":"L Xu","year":"2023","unstructured":"Xu L, Weng S, Li S, et al. Engineering the Intestinal Lymphatic Transport of Oral Nanoparticles to Educate Macrophages for Cancer Combined Immunotherapy. ACS Nano. 2023;17(12):11817\u201337.","journal-title":"ACS Nano"},{"key":"4821_CR7","doi-asserted-by":"publisher","first-page":"114235","DOI":"10.1016\/j.jconrel.2025.114235","volume":"387","author":"S Xu","year":"2025","unstructured":"Xu S, Shao J, Miao Z, et al. Dual STING activation and CD47\/SIRP\u03b1 blockade via chitooligosaccharide-based nanoparticles to amplify antitumor immunity. J Control Release. 2025;387:114235.","journal-title":"J Control Release"},{"issue":"33","key":"4821_CR8","doi-asserted-by":"publisher","first-page":"e2503087","DOI":"10.1002\/adma.202503087","volume":"37","author":"S Zhang","year":"2025","unstructured":"Zhang S, Zhu H, Peng X, et al. Efficient Artificial T Cell Therapy for Bacterial-Colonized Tumors. Adv Mater. 2025;37(33):e2503087.","journal-title":"Adv Mater"},{"issue":"2","key":"4821_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jvir.2023.10.009","volume":"35","author":"I Altun","year":"2024","unstructured":"Altun I, Demirlenk YM, Atar D, et al. Advances and Challenges in Interventional Immuno-Oncology Locoregional Therapies. J Vasc Interv Radiol. 2024;35(2):164\u201372.","journal-title":"J Vasc Interv Radiol"},{"key":"4821_CR10","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1016\/j.ijbiomac.2020.09.042","volume":"164","author":"W Wang","year":"2020","unstructured":"Wang W, Xue C, Mao X, Chitosan. Structural modification, biological activity and application. Int J Biol Macromol. 2020;164:4532\u201346.","journal-title":"Int J Biol Macromol"},{"key":"4821_CR11","doi-asserted-by":"publisher","first-page":"119132","DOI":"10.1016\/j.carbpol.2022.119132","volume":"282","author":"SG Kou","year":"2022","unstructured":"Kou SG, Peters L, Mucalo M, Chitosan. A review of molecular structure, bioactivities and interactions with the human body and micro-organisms. Carbohydr Polym. 2022;282:119132.","journal-title":"Carbohydr Polym"},{"key":"4821_CR12","doi-asserted-by":"publisher","first-page":"119452","DOI":"10.1016\/j.carbpol.2022.119452","volume":"290","author":"X Liang","year":"2022","unstructured":"Liang X, Mu M, Fan R, Zou B, Guo G. Functionalized chitosan as a promising platform for cancer immunotherapy: A review. Carbohydr Polym. 2022;290:119452.","journal-title":"Carbohydr Polym"},{"key":"4821_CR13","doi-asserted-by":"publisher","first-page":"124398","DOI":"10.1016\/j.ijbiomac.2023.124398","volume":"240","author":"W Tang","year":"2023","unstructured":"Tang W, Wang J, Hou H, et al. Review: Application of chitosan and its derivatives in medical materials. Int J Biol Macromol. 2023;240:124398.","journal-title":"Int J Biol Macromol"},{"issue":"12","key":"4821_CR14","doi-asserted-by":"publisher","first-page":"e2418583","DOI":"10.1002\/adma.202418583","volume":"37","author":"S Zhang","year":"2025","unstructured":"Zhang S, Wang C, Zhu Y, et al. DNA-Capturing Manganese-Coordinated Chitosan Microparticles Potentiate Radiotherapy via Activating the cGAS-STING Pathway and Maintaining Tumor-Infiltrating CD8\u2009+\u2009T-Cell Stemness. Adv Mater. 2025;37(12):e2418583.","journal-title":"Adv Mater"},{"issue":"Pt 1","key":"4821_CR15","doi-asserted-by":"publisher","first-page":"149674","DOI":"10.1016\/j.ijbiomac.2025.149674","volume":"338","author":"EM El-Fakharany","year":"2026","unstructured":"El-Fakharany EM, Al Kamaly O, El-Sayed MH, El-Maradny YA. Fabrication and characterization of functionalized chitosan nanoparticles with Lactoferrin as a multifunctional nanocarrier for anticancer applications. Int J Biol Macromol. 2026;338(Pt 1):149674.","journal-title":"Int J Biol Macromol"},{"issue":"15","key":"4821_CR16","doi-asserted-by":"publisher","first-page":"6192","DOI":"10.1158\/0008-5472.CAN-09-1114","volume":"69","author":"DA Zaharoff","year":"2009","unstructured":"Zaharoff DA, Hoffman BS, Hooper HB, et al. Intravesical immunotherapy of superficial bladder cancer with chitosan\/interleukin-12. Cancer Res. 2009;69(15):6192\u20139.","journal-title":"Cancer Res"},{"issue":"33","key":"4821_CR17","doi-asserted-by":"publisher","first-page":"30046","DOI":"10.1021\/acsnano.5c05354","volume":"19","author":"Y Xu","year":"2025","unstructured":"Xu Y, Yan X, Zhang F, et al. Intranasal Delivery of HPV Therapeutic Vaccines for Enhanced Mucosal Immunization and Anti-Tumor Immunity. ACS Nano. 2025;19(33):30046\u201359.","journal-title":"ACS Nano"},{"key":"4821_CR18","doi-asserted-by":"crossref","unstructured":"Hoover AR, Liu K, Furrer C et al. N-dihydrogalactochitosan drives conventional and alternative activations of STING to Synergize type I IFN and IL-1\u03b2 productions for antitumor immunity. Adv Funct Mater. 2024;34(51):2410079.","DOI":"10.1002\/adfm.202410079"},{"key":"4821_CR19","doi-asserted-by":"publisher","first-page":"102992","DOI":"10.1016\/j.mtbio.2026.102992","volume":"37","author":"J Lin","year":"2026","unstructured":"Lin J, Li B, Wang X, et al. Chitosan-based hydrogel facilitates DC-SIGN-mediated monocyte-to-dendritic cell transformation in vivo for antigen-specific antitumor therapy. Mater Today Bio. 2026;37:102992.","journal-title":"Mater Today Bio"},{"issue":"15","key":"4821_CR20","first-page":"4295","volume":"62","author":"WR Chen","year":"2002","unstructured":"Chen WR, Liu H, Ritchey JW, Bartels KE, Lucroy MD, Nordquist RE. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats. Cancer Res. 2002;62(15):4295\u20139.","journal-title":"Cancer Res"},{"issue":"5","key":"4821_CR21","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1021\/acsnano.2c09266","volume":"17","author":"W Zhu","year":"2023","unstructured":"Zhu W, Chao Y, Jin Q, et al. Oral Delivery of Therapeutic Antibodies with a Transmucosal Polymeric Carrier. ACS Nano. 2023;17(5):4373\u201386.","journal-title":"ACS Nano"},{"key":"4821_CR22","doi-asserted-by":"publisher","first-page":"124244","DOI":"10.1016\/j.carbpol.2025.124244","volume":"369","author":"J Li","year":"2025","unstructured":"Li J, Zhao J, Ye J, et al. A versatile chitosan hydrogel crosslinked by boronated diol drug conjugates as anti-tumor immune stimulator for hepatocellular carcinoma treatment. Carbohydr Polym. 2025;369:124244.","journal-title":"Carbohydr Polym"},{"issue":"6","key":"4821_CR23","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1021\/nn5002112","volume":"8","author":"L Guo","year":"2014","unstructured":"Guo L, Yan DD, Yang D, et al. Combinatorial photothermal and immuno cancer therapy using chitosan-coated hollow copper sulfide nanoparticles. ACS Nano. 2014;8(6):5670\u201381.","journal-title":"ACS Nano"},{"issue":"2","key":"4821_CR24","doi-asserted-by":"publisher","first-page":"eadz5078","DOI":"10.1126\/sciadv.adz5078","volume":"12","author":"F Wang","year":"2026","unstructured":"Wang F, Zeng Y, Yan M, et al. Self-transforming hydrogel mimicking tertiary lymph nodes to activate cGAS-STING pathway for enhanced antitumor immunotherapy. Sci Adv. 2026;12(2):eadz5078.","journal-title":"Sci Adv"},{"issue":"5","key":"4821_CR25","doi-asserted-by":"publisher","first-page":"101560","DOI":"10.1016\/j.xcrm.2024.101560","volume":"5","author":"JL Turley","year":"2024","unstructured":"Turley JL, Ward RW, Huete-Carrasco J, et al. Intratumoral delivery of the chitin-derived C100 adjuvant promotes robust STING, IFNAR, and CD8\u2009+\u2009T cell-dependent anti-tumor immunity. Cell Rep Med. 2024;5(5):101560.","journal-title":"Cell Rep Med"},{"key":"4821_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.actbio.2026.01.014","volume":"212","author":"T Li","year":"2026","unstructured":"Li T, Wang Y, Zhu J, et al. Matrix-modulating pH-gated hydrogel for coordinated regulation of cancer-associated fibroblast phenotype and Mn2+-STING activation for enhanced tumor immunotherapy. Acta Biomater. 2026;212:655\u201370.","journal-title":"Acta Biomater"},{"issue":"71","key":"4821_CR27","doi-asserted-by":"publisher","first-page":"9550","DOI":"10.1039\/D4CC03445G","volume":"60","author":"K Ma","year":"2024","unstructured":"Ma K, Chen Z, Liang K, Pei Y, Pei Z. A near-infrared light-driven Janus nanomotor for deep tumor penetration and enhanced tumor immunotherapy. Chem Commun (Camb). 2024;60(71):9550\u20133.","journal-title":"Chem Commun (Camb)"},{"key":"4821_CR28","doi-asserted-by":"publisher","first-page":"121346","DOI":"10.1016\/j.carbpol.2023.121346","volume":"321","author":"S Zhang","year":"2023","unstructured":"Zhang S, Zeng Y, Wang K, et al. Chitosan-based nano-micelles for potential anti-tumor immunotherapy: Synergistic effect of cGAS-STING signaling pathway activation and tumor antigen absorption. Carbohydr Polym. 2023;321:121346.","journal-title":"Carbohydr Polym"},{"issue":"6","key":"4821_CR29","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.coi.2008.10.002","volume":"20","author":"CG Lee","year":"2008","unstructured":"Lee CG, Da Silva CA, Lee JY, Hartl D, Elias JA. Chitin regulation of immune responses: an old molecule with new roles. Curr Opin Immunol. 2008;20(6):684\u20139.","journal-title":"Curr Opin Immunol"},{"key":"4821_CR30","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.jconrel.2025.01.042","volume":"379","author":"F Castro","year":"2025","unstructured":"Castro F, Pinto ML, Leite Pereira C, et al. Chitosan\/\u03b3-PGA nanoparticles and IFN-\u03b3 immunotherapy: A dual approach for triple-negative breast cancer treatment. J Control Release. 2025;379:621\u201335.","journal-title":"J Control Release"},{"issue":"1","key":"4821_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cellimm.2013.11.006","volume":"287","author":"A Chakrabarti","year":"2014","unstructured":"Chakrabarti A, Talukdar D, Pal A, Ray M. Immunomodulation of macrophages by methylglyoxal conjugated with chitosan nanoparticles against Sarcoma-180 tumor in mice. Cell Immunol. 2014;287(1):27\u201335.","journal-title":"Cell Immunol"},{"issue":"6","key":"4821_CR32","doi-asserted-by":"publisher","first-page":"e1431085","DOI":"10.1080\/2162402X.2018.1431085","volume":"7","author":"X Li","year":"2018","unstructured":"Li X, Dong W, Nalin AP, et al. The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cells. Oncoimmunology. 2018;7(6):e1431085.","journal-title":"Oncoimmunology"},{"issue":"11","key":"4821_CR33","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1080\/03639045.2022.2045306","volume":"47","author":"Z Ji","year":"2021","unstructured":"Ji Z, Xu J, Li M, et al. The mechanisms of immune-chemotherapy with nanocomplex codelivery of pTRP-2 and adjuvant of paclitaxel against melanoma. Drug Dev Ind Pharm. 2021;47(11):1744\u201352.","journal-title":"Drug Dev Ind Pharm"},{"issue":"Pt 2","key":"4821_CR34","doi-asserted-by":"publisher","first-page":"115059","DOI":"10.1016\/j.colsurfb.2025.115059","volume":"256","author":"C Li","year":"2025","unstructured":"Li C, Ma W, Shen H, et al. Natural polysaccharides in colloidal drug delivery systems for brain glioma therapy: Mechanisms and advancements. Colloids Surf B Biointerfaces. 2025;256(Pt 2):115059.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4821_CR35","doi-asserted-by":"crossref","unstructured":"Zheng B, Wen ZS, Huang YJ, Xia MS, Xiang XW, Qu YL. Molecular weight-dependent immunostimulative activity of low molecular weight chitosan via regulating NF-\u03baB and AP-1 signaling pathways in RAW264.7 macrophages. Mar Drugs. 2016;14(9):169.","DOI":"10.3390\/md14090169"},{"issue":"5","key":"4821_CR36","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s12032-025-02714-4","volume":"42","author":"S Alharthi","year":"2025","unstructured":"Alharthi S, Alrashidi AA, Ziora Z, Ebrahimi Shahmabadi H, Alavi SE. Innovative PEGylated chitosan nanocarriers for co-delivery of doxorubicin and CpG in breast cancer therapy: Preparation, characterization, and immunotherapeutic potential. Med Oncol. 2025;42(5):176.","journal-title":"Med Oncol"},{"issue":"2","key":"4821_CR37","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1021\/acsbiomaterials.5c01546","volume":"12","author":"X Li","year":"2026","unstructured":"Li X, Xie J, Song SJ, Ahlquist C, Kim H. Sialic Acid Binding Liposome Nanoparticles for Targeted Bladder Cancer Therapy. ACS Biomater Sci Eng. 2026;12(2):971\u201385.","journal-title":"ACS Biomater Sci Eng"},{"key":"4821_CR38","doi-asserted-by":"publisher","first-page":"122703","DOI":"10.1016\/j.biomaterials.2024.122703","volume":"311","author":"J Lin","year":"2024","unstructured":"Lin J, Zhou Y, Li C, et al. Hydrogel activation of Mincle receptors for tumor cell processing: A novel approach in cancer immunotherapy. Biomaterials. 2024;311:122703.","journal-title":"Biomaterials"},{"issue":"4","key":"4821_CR39","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/jbm.a.35991","volume":"105","author":"A El-Hussein","year":"2017","unstructured":"El-Hussein A, Lam S, Raker J, Chen WR, Hamblin MR. N-dihydrogalactochitosan as a potent immune activator for dendritic cells. J Biomed Mater Res A. 2017;105(4):963\u201372.","journal-title":"J Biomed Mater Res A"},{"key":"4821_CR40","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.3389\/fphar.2018.01412","volume":"9","author":"X Guo","year":"2018","unstructured":"Guo X, Sun T, Zhong R, et al. Effects of Chitosan Oligosaccharides on Human Blood Components. Front Pharmacol. 2018;9:1412.","journal-title":"Front Pharmacol"},{"issue":"9","key":"4821_CR41","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/CJI.0000000000000572","volume":"48","author":"DA Goodin","year":"2025","unstructured":"Goodin DA, Daunke T, Beckinger S, et al. Synergistic Effect of Anti-PD-L1 Treatment and CD8\u2009+\u2009T-Cell Activating Nanotherapy in Pancreatic Ductal Adenocarcinoma Evaluated via 3D Mathematical Modeling. J Immunother. 2025;48(9):331\u201342.","journal-title":"J Immunother"},{"key":"4821_CR42","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jconrel.2024.07.050","volume":"373","author":"Y Hou","year":"2024","unstructured":"Hou Y, Kong F, Tang Z, et al. Nitroxide radical conjugated ovalbumin theranostic nanosystem for enhanced dendritic cell-based immunotherapy and T1 magnetic resonance imaging. J Control Release. 2024;373:547\u201363.","journal-title":"J Control Release"},{"issue":"Pt 1","key":"4821_CR43","doi-asserted-by":"publisher","first-page":"148934","DOI":"10.1016\/j.ijbiomac.2025.148934","volume":"334","author":"W Hu","year":"2025","unstructured":"Hu W, Ma Y, Zhang Q, et al. DCs-targeted full-cell nanovaccine based on chitosan oligosaccharide self-assembled with ganoderma lucidum polysaccharide for enhancing tumor immunotherapy. Int J Biol Macromol. 2025;334(Pt 1):148934.","journal-title":"Int J Biol Macromol"},{"issue":"31","key":"4821_CR44","doi-asserted-by":"publisher","first-page":"8867","DOI":"10.1016\/j.biomaterials.2014.07.014","volume":"35","author":"YC Lin","year":"2014","unstructured":"Lin YC, Lou PJ, Young TH. Chitosan as an adjuvant-like substrate for dendritic cell culture to enhance antitumor effects. Biomaterials. 2014;35(31):8867\u201375.","journal-title":"Biomaterials"},{"key":"4821_CR45","doi-asserted-by":"publisher","unstructured":"Zhang X, Chen W, Zhang K, Liu Z, Lyu Q, Jin L, Liu W. Exploration of the synergistic effect of chitosan oligosaccharide and dacarbazine (DTIC) in the treatment of melanoma. Curr Cancer Drug Target. 2026. https:\/\/doi.org\/10.2174\/0115680096423297251202110111. Epub ahead of print. PMID: 41928641.","DOI":"10.2174\/0115680096423297251202110111"},{"issue":"4","key":"4821_CR46","doi-asserted-by":"publisher","first-page":"6410","DOI":"10.1021\/acsami.5c17578","volume":"18","author":"W Chen","year":"2026","unstructured":"Chen W, Gao N, Sun Y, et al. A Drug-Free Polysaccharide Hydrogel Encapsulating Iron Oxide Nanoparticles against Postoperative Tumor Recurrence and Metastasis. ACS Appl Mater Interfaces. 2026;18(4):6410\u201322.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"Pt 4","key":"4821_CR47","doi-asserted-by":"publisher","first-page":"135608","DOI":"10.1016\/j.ijbiomac.2024.135608","volume":"280","author":"AE Chuang","year":"2024","unstructured":"Chuang AE, Tao YK, Dong SW, Nguyen HT, Liu CH. Polypyrrole\/iron-glycol chitosan nanozymes mediate M1 macrophages to enhance the X-ray-triggered photodynamic therapy for bladder cancer by promoting antitumor immunity. Int J Biol Macromol. 2024;280(Pt 4):135608.","journal-title":"Int J Biol Macromol"},{"issue":"10","key":"4821_CR48","doi-asserted-by":"publisher","first-page":"6366","DOI":"10.1021\/acs.nanolett.7b03186","volume":"17","author":"Q Song","year":"2017","unstructured":"Song Q, Yin Y, Shang L, et al. Tumor Microenvironment Responsive Nanogel for the Combinatorial Antitumor Effect of Chemotherapy and Immunotherapy. Nano Lett. 2017;17(10):6366\u201375.","journal-title":"Nano Lett"},{"key":"4821_CR49","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.actbio.2025.01.021","volume":"194","author":"J Li","year":"2025","unstructured":"Li J, Mao K, Meng X, et al. Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy. Acta Biomater. 2025;194:153\u201368.","journal-title":"Acta Biomater"},{"key":"4821_CR50","doi-asserted-by":"crossref","unstructured":"Thomas R, Fukamizo T, Suginta W. Green-chemical strategies for production of tailor-made chitooligosaccharides with enhanced biological activities. Molecules. 2023;28(18):6591.","DOI":"10.3390\/molecules28186591"},{"issue":"6","key":"4821_CR51","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1007\/s42114-025-01492-x","volume":"8","author":"K Song","year":"2025","unstructured":"Song K, Ren L, Guo X, et al. Microbiota-responsive oral nano-amifostine enables colorectal-specific radioprotection and tumor immunity via gut microenvironment reprogramming. Adv Compos Hybrid Mater. 2025;8(6):432.","journal-title":"Adv Compos Hybrid Mater"},{"key":"4821_CR52","doi-asserted-by":"publisher","first-page":"217825","DOI":"10.1016\/j.canlet.2025.217825","volume":"627","author":"K Liu","year":"2026","unstructured":"Liu K, Hoover AR, Sun Y, et al. Anti-tumor effects on tumor-infiltrating natural killer cells by localized ablative immunotherapy and immune checkpoint inhibitors: An integrated and comparative study using scRNAseq analysis. Cancer Lett. 2026;627:217825.","journal-title":"Cancer Lett"},{"issue":"4","key":"4821_CR53","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/jn\/134.4.945","volume":"134","author":"Y Maeda","year":"2004","unstructured":"Maeda Y, Kimura Y. Antitumor effects of various low-molecular-weight chitosans are due to increased natural killer activity of intestinal intraepithelial lymphocytes in sarcoma 180-bearing mice. J Nutr. 2004;134(4):945\u201350.","journal-title":"J Nutr"},{"key":"4821_CR54","doi-asserted-by":"publisher","first-page":"9325","DOI":"10.2147\/IJN.S212898","volume":"14","author":"L Lin","year":"2019","unstructured":"Lin L, He J, Li J, Xu Y, Li J, Wu Y. Chitosan Nanoparticles Strengthen V\u03b39V\u03b42 T-Cell Cytotoxicity Through Upregulation Of Killing Molecules And Cytoskeleton Polarization. Int J Nanomed. 2019;14:9325\u201336.","journal-title":"Int J Nanomed"},{"issue":"Pt 4","key":"4821_CR55","doi-asserted-by":"publisher","first-page":"136513","DOI":"10.1016\/j.ijbiomac.2024.136513","volume":"281","author":"C Miron","year":"2024","unstructured":"Miron C, Andreica B, Iftime MM, et al. Cold plasma irradiation of chitosan: A straight pathway to selective antitumor therapy. Int J Biol Macromol. 2024;281(Pt 4):136513.","journal-title":"Int J Biol Macromol"},{"key":"4821_CR56","doi-asserted-by":"publisher","first-page":"118132","DOI":"10.1016\/j.carbpol.2021.118132","volume":"266","author":"X Zhai","year":"2021","unstructured":"Zhai X, Li C, Ren D, Wang J, Ma C, Abd El-Aty AM. The impact of chitooligosaccharides and their derivatives on the in vitro and in vivo antitumor activity: A comprehensive review. Carbohydr Polym. 2021;266:118132.","journal-title":"Carbohydr Polym"},{"issue":"1","key":"4821_CR57","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1080\/10717544.2021.1921076","volume":"28","author":"Z Zeng","year":"2021","unstructured":"Zeng Z, Liu Y, Wen Q, et al. Experimental study on preparation and anti-tumor efficiency of nanoparticles targeting M2 macrophages. Drug Deliv. 2021;28(1):943\u201356.","journal-title":"Drug Deliv"},{"key":"4821_CR58","doi-asserted-by":"publisher","first-page":"217267","DOI":"10.1016\/j.canlet.2024.217267","volume":"604","author":"K Liu","year":"2024","unstructured":"Liu K, Hoover AR, Wang L, et al. Localized ablative immunotherapy enhances antitumor immunity by modulating the transcriptome of tumor-infiltrating Gamma delta T cells. Cancer Lett. 2024;604:217267.","journal-title":"Cancer Lett"},{"issue":"9","key":"4821_CR59","doi-asserted-by":"publisher","first-page":"e2305275","DOI":"10.1002\/advs.202305275","volume":"11","author":"S Liang","year":"2024","unstructured":"Liang S, Liu M, Mu W, et al. Nano-Regulator Inhibits Tumor Immune Escape via the Two-Way Regulation Epigenetic Therapy Strategy. Adv Sci (Weinh). 2024;11(9):e2305275.","journal-title":"Adv Sci (Weinh)"},{"key":"4821_CR60","doi-asserted-by":"publisher","first-page":"5675","DOI":"10.2147\/IJN.S318363","volume":"16","author":"X Liu","year":"2021","unstructured":"Liu X, Xu Y, Yin L, Hou Y, Zhao S. Chitosan-Poly(Acrylic Acid) Nanoparticles Loaded with R848 and MnCl2 Inhibit Melanoma via Regulating Macrophage Polarization and Dendritic Cell Maturation. Int J Nanomed. 2021;16:5675\u201392.","journal-title":"Int J Nanomed"},{"issue":"Pt 3","key":"4821_CR61","doi-asserted-by":"publisher","first-page":"135327","DOI":"10.1016\/j.ijbiomac.2024.135327","volume":"279","author":"S Victoria","year":"2024","unstructured":"Victoria S, Castro A, Pittini A, et al. Formulating a TMEM176B blocker in chitosan nanoparticles uncouples its paradoxical roles in innate and adaptive antitumoral immunity. Int J Biol Macromol. 2024;279(Pt 3):135327.","journal-title":"Int J Biol Macromol"},{"issue":"52","key":"4821_CR62","doi-asserted-by":"publisher","first-page":"8673","DOI":"10.1016\/j.vaccine.2007.10.037","volume":"25","author":"DA Zaharoff","year":"2007","unstructured":"Zaharoff DA, Rogers CJ, Hance KW, Schlom J, Greiner JW. Chitosan solution enhances the immunoadjuvant properties of GM-CSF. Vaccine. 2007;25(52):8673\u201386.","journal-title":"Vaccine"},{"key":"4821_CR63","doi-asserted-by":"publisher","unstructured":"Vrabel MR, Schulman JA, Gillam FB, Mantooth SM, Nguyen KG, Zaharoff DA. Focal cryo-immunotherapy with intratumoral IL-12 prevents recurrence of large murine tumors. Cancers (Basel). 2023;15(8):2210. https:\/\/doi.org\/10.3390\/cancers15082210.","DOI":"10.3390\/cancers15082210"},{"key":"4821_CR64","doi-asserted-by":"publisher","first-page":"113761","DOI":"10.1016\/j.jconrel.2025.113761","volume":"383","author":"SM Mantooth","year":"2025","unstructured":"Mantooth SM, Green JM, Green WD, et al. An injectable hydrogel enhances intratumoral retention and antitumor efficacy of cytokine immunotherapy in murine triple negative breast tumor models. J Control Release. 2025;383:113761.","journal-title":"J Control Release"},{"issue":"15","key":"4821_CR65","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1016\/j.biomaterials.2013.02.031","volume":"34","author":"L Yang","year":"2013","unstructured":"Yang L, Zaharoff DA. Role of chitosan co-formulation in enhancing interleukin-12 delivery and antitumor activity. Biomaterials. 2013;34(15):3828\u201336.","journal-title":"Biomaterials"},{"issue":"1","key":"4821_CR66","doi-asserted-by":"publisher","first-page":"e1259050","DOI":"10.1080\/2162402X.2016.1259050","volume":"6","author":"SG Smith","year":"2017","unstructured":"Smith SG, Baltz JL, Koppolu BP, Ravindranathan S, Nguyen K, Zaharoff DA. Immunological mechanisms of intravesical chitosan\/interleukin-12 immunotherapy against murine bladder cancer. Oncoimmunology. 2017;6(1):e1259050.","journal-title":"Oncoimmunology"},{"key":"4821_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ebiom.2018.09.050","volume":"37","author":"J Zhang","year":"2018","unstructured":"Zhang J, Jiang H, Zhang H. In situ administration of cytokine combinations induces tumor regression in mice. EBioMedicine. 2018;37:38\u201346.","journal-title":"EBioMedicine"},{"key":"4821_CR68","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.actbio.2016.10.012","volume":"47","author":"J Wu","year":"2017","unstructured":"Wu J, Tang C, Yin C. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy. Acta Biomater. 2017;47:81\u201390.","journal-title":"Acta Biomater"},{"issue":"7","key":"4821_CR69","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/CJI.0b013e3181eb826d","volume":"33","author":"DA Zaharoff","year":"2010","unstructured":"Zaharoff DA, Hance KW, Rogers CJ, Schlom J, Greiner JW. Intratumoral immunotherapy of established solid tumors with chitosan\/IL-12. J Immunother. 2010;33(7):697\u2013705.","journal-title":"J Immunother"},{"issue":"12","key":"4821_CR70","doi-asserted-by":"publisher","first-page":"e968001","DOI":"10.4161\/21624011.2014.968001","volume":"3","author":"JL Vo","year":"2014","unstructured":"Vo JL, Yang L, Kurtz SL, et al. Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasis. Oncoimmunology. 2014;3(12):e968001.","journal-title":"Oncoimmunology"},{"issue":"4","key":"4821_CR71","doi-asserted-by":"publisher","first-page":"eabq3104","DOI":"10.1126\/sciadv.abq3104","volume":"9","author":"J Shen","year":"2023","unstructured":"Shen J, Gao H, Chen L, et al. Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment. Sci Adv. 2023;9(4):eabq3104.","journal-title":"Sci Adv"},{"key":"4821_CR72","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12929-014-0069-z","volume":"21","author":"A Tahamtan","year":"2014","unstructured":"Tahamtan A, Ghaemi A, Gorji A, et al. Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems. J Biomed Sci. 2014;21:69.","journal-title":"J Biomed Sci"},{"key":"4821_CR73","doi-asserted-by":"crossref","unstructured":"Robles-Planells C, Barrera-Avalos C, Rojo LE et al. Chitosan-Based Delivery of Avian Reovirus Fusogenic Protein p10 Gene. Biomed Res Int. 2020. 2020: 4045760.","DOI":"10.1155\/2020\/4045760"},{"issue":"8","key":"4821_CR74","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1021\/mp4000053","volume":"10","author":"W Yao","year":"2013","unstructured":"Yao W, Peng Y, Du M, Luo J, Zong L. Preventative vaccine-loaded mannosylated chitosan nanoparticles intended for nasal mucosal delivery enhance immune responses and potent tumor immunity. Mol Pharm. 2013;10(8):2904\u201314.","journal-title":"Mol Pharm"},{"issue":"3","key":"4821_CR75","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.bbrc.2015.05.065","volume":"463","author":"C Yan","year":"2015","unstructured":"Yan C, Jie L, Yongqi W, et al. Delivery of human NKG2D-IL-15 fusion gene by chitosan nanoparticles to enhance antitumor immunity. Biochem Biophys Res Commun. 2015;463(3):336\u201343.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"4821_CR76","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1158\/1535-7163.MCT-05-0540","volume":"5","author":"TH Kim","year":"2006","unstructured":"Kim TH, Jin H, Kim HW, Cho MH, Cho CS. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB\/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther. 2006;5(7):1723\u201332.","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"4821_CR77","doi-asserted-by":"publisher","first-page":"752","DOI":"10.7150\/thno.14527","volume":"6","author":"J He","year":"2016","unstructured":"He J, Duan S, Yu X, et al. Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte Responses. Theranostics. 2016;6(5):752\u201361.","journal-title":"Theranostics"},{"key":"4821_CR78","doi-asserted-by":"publisher","first-page":"3095","DOI":"10.2147\/IJN.S128032","volume":"12","author":"L Tan","year":"2017","unstructured":"Tan L, Han S, Ding S, et al. Chitosan nanoparticle-based delivery of fused NKG2D-IL-21 gene suppresses colon cancer growth in mice. Int J Nanomed. 2017;12:3095\u2013107.","journal-title":"Int J Nanomed"},{"key":"4821_CR79","doi-asserted-by":"publisher","first-page":"124835","DOI":"10.1016\/j.ijpharm.2024.124835","volume":"666","author":"HE Kim","year":"2024","unstructured":"Kim HE, Na YG, Jin M, et al. Fabrication and evaluation of chitosan-coated nanostructured lipid carriers for co-delivery of paclitaxel and PD-L1 siRNA. Int J Pharm. 2024;666:124835.","journal-title":"Int J Pharm"},{"key":"4821_CR80","doi-asserted-by":"publisher","first-page":"120837","DOI":"10.1016\/j.carbpol.2023.120837","volume":"312","author":"P Song","year":"2023","unstructured":"Song P, Wang B, Pan Q, et al. GE11-modified carboxymethyl chitosan micelles to deliver DOX\u00b7PD-L1 siRNA complex for combination of ICD and immune escape inhibition against tumor. Carbohydr Polym. 2023;312:120837.","journal-title":"Carbohydr Polym"},{"key":"4821_CR81","doi-asserted-by":"publisher","first-page":"118847","DOI":"10.1016\/j.lfs.2020.118847","volume":"266","author":"S Bastaki","year":"2021","unstructured":"Bastaki S, Aravindhan S, Ahmadpour Saheb N, et al. Codelivery of STAT3 and PD-L1 siRNA by hyaluronate-TAT trimethyl\/thiolated chitosan nanoparticles suppresses cancer progression. Life Sci. 2021;266:118847.","journal-title":"Life Sci"},{"key":"4821_CR82","doi-asserted-by":"publisher","first-page":"121008","DOI":"10.1016\/j.lfs.2022.121008","volume":"309","author":"S Adibfar","year":"2022","unstructured":"Adibfar S, Masjedi A, Nazer A, et al. Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression. Life Sci. 2022;309:121008.","journal-title":"Life Sci"},{"key":"4821_CR83","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jconrel.2016.12.012","volume":"246","author":"F Jadidi-Niaragh","year":"2017","unstructured":"Jadidi-Niaragh F, Atyabi F, Rastegari A, et al. CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice. J Control Release. 2017;246:46\u201359.","journal-title":"J Control Release"},{"key":"4821_CR84","doi-asserted-by":"publisher","first-page":"119369","DOI":"10.1016\/j.lfs.2021.119369","volume":"275","author":"N Joshi","year":"2021","unstructured":"Joshi N, Hajizadeh F, Ansari Dezfouli E, et al. Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression. Life Sci. 2021;275:119369.","journal-title":"Life Sci"},{"issue":"1","key":"4821_CR85","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/imm.13126","volume":"159","author":"H Hassannia","year":"2020","unstructured":"Hassannia H, Ghasemi Chaleshtari M, Atyabi F, et al. Blockage of immune checkpoint molecules increases T-cell priming potential of dendritic cell vaccine. Immunology. 2020;159(1):75\u201387.","journal-title":"Immunology"},{"issue":"1","key":"4821_CR86","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1186\/s12885-025-14830-5","volume":"25","author":"R Karami","year":"2025","unstructured":"Karami R, Khodayari S, Eshaghi F, et al. The concurrent silencing of Tim-3 and STAT-3 promotes tumor regression both in vitro and in ovo. BMC Cancer. 2025;25(1):1431.","journal-title":"BMC Cancer"},{"key":"4821_CR87","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2147\/IJN.S340926","volume":"17","author":"X Zhang","year":"2022","unstructured":"Zhang X, Qin B, Wang M, et al. Dual pH-Responsive and Tumor-Targeted Nanoparticle-Mediated Anti-Angiogenesis siRNA Delivery for Tumor Treatment. Int J Nanomed. 2022;17:953\u201367.","journal-title":"Int J Nanomed"},{"issue":"1","key":"4821_CR88","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s12951-024-02612-3","volume":"22","author":"S Chen","year":"2024","unstructured":"Chen S, He Y, Huang X, et al. Photosensitive and dual-targeted chromium nanoparticle delivering small interfering RNA YTHDF1 for molecular-targeted immunotherapy in liver cancer. J Nanobiotechnol. 2024;22(1):348.","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"4821_CR89","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1021\/acsbiomaterials.4c00426","volume":"10","author":"Y Hou","year":"2024","unstructured":"Hou Y, Wang Z, Chen Z, et al. Noninvasive Transdermal Administration of mRNA Vaccines Encoding Multivalent Neoantigens Effectively Inhibits Melanoma Growth. ACS Biomater Sci Eng. 2024;10(7):4587\u2013600.","journal-title":"ACS Biomater Sci Eng"},{"key":"4821_CR90","doi-asserted-by":"publisher","first-page":"138346","DOI":"10.1016\/j.ijbiomac.2024.138346","volume":"286","author":"JS Lee","year":"2025","unstructured":"Lee JS, Cho SH, Park SY, et al. Chitosan-coated PLA\/poloxamer nanoparticles stimulate immunologic cancer cell death and synergistic chemo-immunotherapeutic efficacy. Int J Biol Macromol. 2025;286:138346.","journal-title":"Int J Biol Macromol"},{"key":"4821_CR91","doi-asserted-by":"publisher","first-page":"100350","DOI":"10.1016\/j.mtbio.2022.100350","volume":"16","author":"C Song","year":"2022","unstructured":"Song C, Zhang J, Wen R, et al. Improved anti-hepatocellular carcinoma effect by enhanced Co-delivery of Tim-3 siRNA and sorafenib via multiple pH triggered drug-eluting nanoparticles. Mater Today Bio. 2022;16:100350.","journal-title":"Mater Today Bio"},{"issue":"1","key":"4821_CR92","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12967-025-06293-w","volume":"23","author":"N Rastegar-Pouyani","year":"2025","unstructured":"Rastegar-Pouyani N, Farzin MA, Zafari J, Haji Abdolvahab M, Hassani S. Repurposing the anti-parasitic agent pentamidine for cancer therapy. J Transl Med. 2025;23(1):258.","journal-title":"J Transl Med"},{"issue":"1","key":"4821_CR93","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1186\/s12906-023-04212-4","volume":"23","author":"A Hamed","year":"2023","unstructured":"Hamed A, Ghareeb D, Mohamed TM, Hamed M, Nofal MS, Gaber M. Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade. BMC Complement Med Ther. 2023;23(1):384.","journal-title":"BMC Complement Med Ther"},{"key":"4821_CR94","doi-asserted-by":"crossref","unstructured":"Song H, Su C, Cui W et al. Folic acid-chitosan conjugated nanoparticles for improving tumor-targeted drug delivery. Biomed Res Int. 2013. 2013: 723158.","DOI":"10.1155\/2013\/723158"},{"issue":"5","key":"4821_CR95","doi-asserted-by":"publisher","first-page":"e2406975","DOI":"10.1002\/advs.202406975","volume":"12","author":"L Shen","year":"2025","unstructured":"Shen L, Yang Z, Zhong Y, et al. Cholesterol Targeted Catalytic Hydrogel Fueled by Tumor Debris can Enhance Microwave Ablation Therapy and Anti-Tumor Immune Response. Adv Sci (Weinh). 2025;12(5):e2406975.","journal-title":"Adv Sci (Weinh)"},{"key":"4821_CR96","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.jconrel.2023.11.050","volume":"365","author":"C Ma","year":"2024","unstructured":"Ma C, Zhong X, Liu R, et al. Co-delivery of oxaliplatin prodrug liposomes with Bacillus Calmette-Gu\u00e9rin for chemo-immunotherapy of orthotopic bladder cancer. J Control Release. 2024;365:640\u201353.","journal-title":"J Control Release"},{"issue":"5","key":"4821_CR97","doi-asserted-by":"publisher","first-page":"5867","DOI":"10.1007\/s00210-024-03658-8","volume":"398","author":"L Rostamizadeh","year":"2025","unstructured":"Rostamizadeh L, Ramezani M, Monirinasab H, et al. Modulating the tumor microenvironment in a mouse model of colon cancer using a combination of HIF-1\u03b1 inhibitors and Toll-Like Receptor 7 agonists. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(5):5867\u201380.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"7","key":"4821_CR98","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s13205-019-1804-7","volume":"9","author":"P Ghasemi-Dehkordi","year":"2019","unstructured":"Ghasemi-Dehkordi P, Doosti A, Jami MS. The concurrent effects of azurin and Mammaglobin-A genes in inhibition of breast cancer progression and immune system stimulation in cancerous BALB\/c mice. 3 Biotech. 2019;9(7):271.","journal-title":"3 Biotech"},{"key":"4821_CR99","doi-asserted-by":"publisher","first-page":"102565","DOI":"10.1016\/j.mtbio.2025.102565","volume":"35","author":"Y Sun","year":"2025","unstructured":"Sun Y, Ye X, Yang L, et al. Oral microbiota-responsive ZIF nanoplatform via double-layer glycans modified combined with PD-1 inhibitor for treatment of microsatellite-stable colorectal cancer. Mater Today Bio. 2025;35:102565.","journal-title":"Mater Today Bio"},{"issue":"1","key":"4821_CR100","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1021\/acs.biomac.3c00591","volume":"25","author":"P Gierlich","year":"2024","unstructured":"Gierlich P, Donohoe C, Behan K, Kelly DJ, Senge MO, Gomes-da-Silva LC. Antitumor Immunity Mediated by Photodynamic Therapy Using Injectable Chitosan Hydrogels for Intratumoral and Sustained Drug Delivery. Biomacromolecules. 2024;25(1):24\u201342.","journal-title":"Biomacromolecules"},{"issue":"9","key":"4821_CR101","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.1021\/acs.biomac.5c01170","volume":"26","author":"M Li","year":"2025","unstructured":"Li M, Liu Y, Han D, Wu S, Gong J. Multifunctional Nanoplatform Combining Photothermal Therapy and Chemoimmunotherapy for the Treatment of Escherichia coli-Colonized Colorectal Cancer. Biomacromolecules. 2025;26(9):6203\u201318.","journal-title":"Biomacromolecules"},{"key":"4821_CR102","doi-asserted-by":"publisher","first-page":"1153724","DOI":"10.3389\/fimmu.2023.1153724","volume":"14","author":"A Mart\u00ednez-P\u00e9rez","year":"2023","unstructured":"Mart\u00ednez-P\u00e9rez A, Diego-Gonz\u00e1lez L, Vilanova M, Correia A, Sim\u00f3n-V\u00e1zquez R, Gonz\u00e1lez-Fern\u00e1ndez \u00c1. Immunization with nanovaccines containing mutated K-Ras peptides and imiquimod aggravates heterotopic pancreatic cancer induced in mice. Front Immunol. 2023;14:1153724.","journal-title":"Front Immunol"},{"issue":"9","key":"4821_CR103","doi-asserted-by":"publisher","first-page":"e0239369","DOI":"10.1371\/journal.pone.0239369","volume":"15","author":"F Walter","year":"2020","unstructured":"Walter F, Winter E, Rahn S, et al. Chitosan nanoparticles as antigen vehicles to induce effective tumor specific T cell responses. PLoS ONE. 2020;15(9):e0239369.","journal-title":"PLoS ONE"},{"key":"4821_CR104","doi-asserted-by":"publisher","first-page":"38348","DOI":"10.1038\/srep38348","volume":"6","author":"HD Han","year":"2016","unstructured":"Han HD, Byeon Y, Jang JH, et al. In vivo stepwise immunomodulation using chitosan nanoparticles as a platform nanotechnology for cancer immunotherapy. Sci Rep. 2016;6:38348.","journal-title":"Sci Rep"},{"issue":"9","key":"4821_CR105","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1111\/cas.15044","volume":"112","author":"D Chai","year":"2021","unstructured":"Chai D, Zhang Z, Jiang N, et al. Co-immunization with L-Myc enhances CD8\u2009+\u2009or CD103\u2009+\u2009DCs mediated tumor-specific multi-functional CD8\u2009+\u2009T cell responses. Cancer Sci. 2021;112(9):3469\u201383.","journal-title":"Cancer Sci"},{"key":"4821_CR106","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.biomaterials.2016.10.047","volume":"113","author":"GN Shi","year":"2017","unstructured":"Shi GN, Zhang CN, Xu R, et al. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine. Biomaterials. 2017;113:191\u2013202.","journal-title":"Biomaterials"},{"issue":"1","key":"4821_CR107","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s12951-024-02487-4","volume":"22","author":"T Li","year":"2024","unstructured":"Li T, Zhang X, Shi C, Liu Q, Zhao Y. Biomimetic nanodrug blocks CD73 to inhibit adenosine and boosts antitumor immune response synergically with photothermal stimulation. J Nanobiotechnol. 2024;22(1):214.","journal-title":"J Nanobiotechnol"},{"issue":"7","key":"4821_CR108","doi-asserted-by":"publisher","first-page":"e2302752","DOI":"10.1002\/adhm.202302752","volume":"13","author":"N Yang","year":"2024","unstructured":"Yang N, Pan X, Zhou X, et al. Biomimetic Nanoarchitectonics with Chitosan Nanogels for Collaborative Induction of Ferroptosis and Anticancer Immunity for Cancer Therapy. Adv Healthc Mater. 2024;13(7):e2302752.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"4821_CR109","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1186\/s12951-023-02031-w","volume":"21","author":"Q Liu","year":"2023","unstructured":"Liu Q, Hu Y, Zheng P, et al. Exploiting immunostimulatory mechanisms of immunogenic cell death to develop membrane-encapsulated nanoparticles as a potent tumor vaccine. J Nanobiotechnol. 2023;21(1):326.","journal-title":"J Nanobiotechnol"},{"key":"4821_CR110","doi-asserted-by":"crossref","unstructured":"Alrahimi JS, Alotaibi NS, Aldahlawi AM, Basingab FS, Zaher KA. Impact of chitosan nanoparticles-coated dendritic cell-based vaccine as cancer immunotherapy. Vaccines (Basel). 2025;13(5):474.","DOI":"10.3390\/vaccines13050474"},{"issue":"12","key":"4821_CR111","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.4161\/hv.26136","volume":"9","author":"VB Joshi","year":"2013","unstructured":"Joshi VB, Geary SM, Salem AK. Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses. Hum Vaccin Immunother. 2013;9(12):2584\u201390.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"4821_CR112","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/02656736.2020.1802519","volume":"37","author":"MJ Gorbet","year":"2020","unstructured":"Gorbet MJ, Singh A, Mao C, Fiering S, Ranjan A. Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits. Int J Hyperth. 2020;37(3):18\u201333.","journal-title":"Int J Hyperth"},{"issue":"6","key":"4821_CR113","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1021\/acsabm.3c00984","volume":"7","author":"P Patra","year":"2024","unstructured":"Patra P, Upadhyay TK, Alshammari N, Saeed M, Kesari KK. Alginate-Chitosan Biodegradable and Biocompatible Based Hydrogel for Breast Cancer Immunotherapy and Diagnosis. ACS Appl Bio Mater. 2024;7(6):3515\u201334.","journal-title":"ACS Appl Bio Mater"},{"issue":"12","key":"4821_CR114","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1021\/acs.biomac.1c01279","volume":"22","author":"E Mei","year":"2021","unstructured":"Mei E, Chen C, Li C, et al. Injectable and Biodegradable Chitosan Hydrogel-Based Drug Depot Contributes to Synergistic Treatment of Tumors. Biomacromolecules. 2021;22(12):5339\u201348.","journal-title":"Biomacromolecules"},{"issue":"1","key":"4821_CR115","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12951-022-01561-z","volume":"20","author":"J Gu","year":"2022","unstructured":"Gu J, Zhao G, Yu J, et al. Injectable pH-responsive hydrogel for combinatorial chemoimmunotherapy tailored to the tumor microenvironment. J Nanobiotechnol. 2022;20(1):372.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"4821_CR116","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s40824-022-00329-8","volume":"26","author":"H Wu","year":"2022","unstructured":"Wu H, Wei G, Luo L, et al. Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel. Biomater Res. 2022;26(1):77.","journal-title":"Biomater Res"},{"issue":"Pt 2","key":"4821_CR117","doi-asserted-by":"publisher","first-page":"130915","DOI":"10.1016\/j.ijbiomac.2024.130915","volume":"267","author":"J Cao","year":"2024","unstructured":"Cao J, Zhu C, Cao Z, Ke X. CPPs-modified chitosan as permeability-enhancing chemotherapeutic combined with gene therapy nanosystem by thermosensitive hydrogel for the treatment of osteosarcoma. Int J Biol Macromol. 2024;267(Pt 2):130915.","journal-title":"Int J Biol Macromol"},{"issue":"Pt 3","key":"4821_CR118","doi-asserted-by":"publisher","first-page":"142914","DOI":"10.1016\/j.ijbiomac.2025.142914","volume":"310","author":"Y Yu","year":"2025","unstructured":"Yu Y, Duan X, Wang X, et al. Enhanced therapeutic effects of ginseng-derived exosome-like nanoparticles loaded hyaluronic acid injectable hydrogels for breast tumor treatment. Int J Biol Macromol. 2025;310(Pt 3):142914.","journal-title":"Int J Biol Macromol"},{"issue":"22","key":"4821_CR119","doi-asserted-by":"publisher","first-page":"8801","DOI":"10.1021\/acs.nanolett.2c01994","volume":"22","author":"C Gao","year":"2022","unstructured":"Gao C, Cheng K, Li Y, et al. Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pancreatic Cancer Therapy. Nano Lett. 2022;22(22):8801\u20139.","journal-title":"Nano Lett"},{"key":"4821_CR120","doi-asserted-by":"publisher","first-page":"102689","DOI":"10.1016\/j.mtbio.2025.102689","volume":"36","author":"B Zheng","year":"2026","unstructured":"Zheng B, Xu Z, Zhang Y, et al. Radioactive hydrogel with NETs degradation capacity for the boosted tumor radio-immunotherapy. Mater Today Bio. 2026;36:102689.","journal-title":"Mater Today Bio"},{"key":"4821_CR121","doi-asserted-by":"publisher","first-page":"114632","DOI":"10.1016\/j.jconrel.2026.114632","volume":"391","author":"C Ye","year":"2026","unstructured":"Ye C, Zheng Y, He H, et al. Single-fraction radiotherapy with a bioactive depot of CD39 blockade eradicates malignant tumors. J Control Release. 2026;391:114632.","journal-title":"J Control Release"},{"issue":"20","key":"4821_CR122","doi-asserted-by":"publisher","first-page":"e2300517","DOI":"10.1002\/advs.202300517","volume":"10","author":"J Meng","year":"2023","unstructured":"Meng J, Yang X, Huang J, et al. Ferroptosis-Enhanced Immunotherapy with an Injectable Dextran-Chitosan Hydrogel for the Treatment of Malignant Ascites in Hepatocellular Carcinoma. Adv Sci (Weinh). 2023;10(20):e2300517.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"4821_CR123","doi-asserted-by":"publisher","first-page":"e2304053","DOI":"10.1002\/advs.202304053","volume":"11","author":"L Mu","year":"2024","unstructured":"Mu L, Qi L, Long H, et al. Photothermal Fibrous Chitosan\/Polydopamine Sponge for Intraoperative Hemostasis and Prevention of Tumor Recurrence in Hepatocellular Carcinoma Resection. Adv Sci (Weinh). 2024;11(3):e2304053.","journal-title":"Adv Sci (Weinh)"},{"issue":"49","key":"4821_CR124","first-page":"56774","volume":"15","author":"W Long","year":"2023","unstructured":"Long W, Li S, Yang Y, et al. Self-Cross-Linked Chitosan\/Albumin-Bound Nanoparticle Hydrogel for Inhibition of Postsurgery Malignant Glioma Recurrence. ACS Appl Mater Interfaces. 2023;15(49):56774\u201385.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4821_CR125","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jconrel.2022.04.015","volume":"346","author":"Q Chen","year":"2022","unstructured":"Chen Q, Zhou S, Ding Y, et al. A bio-responsive, cargo-catchable gel for postsurgical tumor treatment via ICD-based immunotherapy. J Control Release. 2022;346:212\u201325.","journal-title":"J Control Release"},{"key":"4821_CR126","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.jconrel.2022.09.006","volume":"350","author":"Q Chen","year":"2022","unstructured":"Chen Q, Li Y, Zhou S, et al. Sequentially sustained release of anticarcinogens for postsurgical chemoimmunotherapy. J Control Release. 2022;350:803\u201314.","journal-title":"J Control Release"},{"issue":"6","key":"4821_CR127","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1021\/acsbiomaterials.2c00284","volume":"8","author":"CI Nkanga","year":"2022","unstructured":"Nkanga CI, Steinmetz NF. Injectable Hydrogel Containing Cowpea Mosaic Virus Nanoparticles Prevents Colon Cancer Growth. ACS Biomater Sci Eng. 2022;8(6):2518\u201325.","journal-title":"ACS Biomater Sci Eng"},{"issue":"14","key":"4821_CR128","doi-asserted-by":"publisher","first-page":"6936","DOI":"10.7150\/thno.58173","volume":"11","author":"X Liang","year":"2021","unstructured":"Liang X, Li L, Li X, et al. A spontaneous multifunctional hydrogel vaccine amplifies the innate immune response. Theranostics. 2021;11(14):6936\u201349.","journal-title":"Theranostics"},{"issue":"2","key":"4821_CR129","doi-asserted-by":"publisher","first-page":"204","DOI":"10.2174\/18715206113136660375","volume":"14","author":"V Phan-Lai","year":"2014","unstructured":"Phan-Lai V, Kievit FM, Florczyk SJ, Wang K, Disis ML, Zhang M. CCL21 and IFN\u03b3 recruit and activate tumor specific T cells in 3D scaffold model of breast cancer. Anticancer Agents Med Chem. 2014;14(2):204\u201310.","journal-title":"Anticancer Agents Med Chem"},{"issue":"5","key":"4821_CR130","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1021\/bm301928u","volume":"14","author":"V Phan-Lai","year":"2013","unstructured":"Phan-Lai V, Florczyk SJ, Kievit FM, et al. Three-dimensional scaffolds to evaluate tumor associated fibroblast-mediated suppression of breast tumor specific T cells. Biomacromolecules. 2013;14(5):1330\u20137.","journal-title":"Biomacromolecules"},{"key":"4821_CR131","doi-asserted-by":"publisher","first-page":"124173","DOI":"10.1016\/j.biomaterials.2026.124173","volume":"333","author":"X Li","year":"2026","unstructured":"Li X, Zong X, Yuan P, et al. An epigenetically enhanced whole-cell vaccine in a stimulatory hydrogel for robust antitumor immunity. Biomaterials. 2026;333:124173.","journal-title":"Biomaterials"},{"issue":"1","key":"4821_CR132","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s42826-022-00122-7","volume":"38","author":"J Santana","year":"2022","unstructured":"Santana J, Marcato PD, Massaro T, Godoy NL, Anibal FF, Borra RC. Efficacy of instillation of MB49 cells and thermoreversible polymeric gel in urothelial bladder carcinoma immunization. Lab Anim Res. 2022;38(1):11.","journal-title":"Lab Anim Res"},{"key":"4821_CR133","doi-asserted-by":"publisher","first-page":"123633","DOI":"10.1016\/j.biomaterials.2025.123633","volume":"326","author":"Y Shi","year":"2026","unstructured":"Shi Y, Wu Q, Yang T, et al. Temperature-activated in situ hydrogel augments tumor treatment. Biomaterials. 2026;326:123633.","journal-title":"Biomaterials"},{"key":"4821_CR134","doi-asserted-by":"publisher","first-page":"122645","DOI":"10.1016\/j.carbpol.2024.122645","volume":"346","author":"Q Tang","year":"2024","unstructured":"Tang Q, Leng S, Tan Y, et al. Chitosan\/dextran-based organohydrogel delivers EZH2 inhibitor to epigenetically reprogram chemo\/immuno-resistance in unresectable metastatic melanoma. Carbohydr Polym. 2024;346:122645.","journal-title":"Carbohydr Polym"},{"issue":"3","key":"4821_CR135","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s10585-008-9228-5","volume":"26","author":"SH Seo","year":"2009","unstructured":"Seo SH, Han HD, Noh KH, Kim TW, Son SW. Chitosan hydrogel containing GMCSF and a cancer drug exerts synergistic anti-tumor effects via the induction of CD8\u2009+\u2009T cell-mediated anti-tumor immunity. Clin Exp Metastasis. 2009;26(3):179\u201387.","journal-title":"Clin Exp Metastasis"},{"issue":"1\u20132","key":"4821_CR136","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpharm.2007.08.014","volume":"350","author":"HD Han","year":"2008","unstructured":"Han HD, Song CK, Park YS, et al. A chitosan hydrogel-based cancer drug delivery system exhibits synergistic antitumor effects by combining with a vaccinia viral vaccine. Int J Pharm. 2008;350(1\u20132):27\u201334.","journal-title":"Int J Pharm"},{"key":"4821_CR137","doi-asserted-by":"publisher","first-page":"118384","DOI":"10.1016\/j.carbpol.2021.118384","volume":"270","author":"L Zhang","year":"2021","unstructured":"Zhang L, Li Q, Chen J, Tang C, Yin C. Enhanced antitumor efficacy of glutathione-responsive chitosan based nanoparticles through co-delivery of chemotherapeutics, genes, and immune agents. Carbohydr Polym. 2021;270:118384.","journal-title":"Carbohydr Polym"},{"key":"4821_CR138","doi-asserted-by":"publisher","first-page":"113745","DOI":"10.1016\/j.jconrel.2025.113745","volume":"382","author":"Q Sun","year":"2025","unstructured":"Sun Q, Shan G, Wang W, et al. Reversing hypoxia-induced immune evasion in tumors to enhance cancer immunotherapy. J Control Release. 2025;382:113745.","journal-title":"J Control Release"},{"key":"4821_CR139","doi-asserted-by":"crossref","unstructured":"Ma H, Zhang L, Wang L et al. pH-responsive selenium nanoplatform for targeted drug release and immune remodeling in microbiota-associated colorectal cancer. J Nanobiotechnol. 2026;24(1):342.","DOI":"10.1186\/s12951-026-04229-0"},{"issue":"38","key":"4821_CR140","doi-asserted-by":"publisher","first-page":"10258","DOI":"10.1016\/j.biomaterials.2013.09.027","volume":"34","author":"D Zhang","year":"2013","unstructured":"Zhang D, Sun P, Li P, et al. A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette-Gu\u00e9rin in the treatment of bladder cancer. Biomaterials. 2013;34(38):10258\u201366.","journal-title":"Biomaterials"},{"issue":"34","key":"4821_CR141","doi-asserted-by":"publisher","first-page":"23497","DOI":"10.1021\/acsnano.4c07115","volume":"18","author":"YT Qin","year":"2024","unstructured":"Qin YT, Liu X, An JX, et al. Oral Saccharomyces cerevisiae-Guided Enzyme Prodrug Therapy Combined with Immunotherapy for the Treatment of Orthotopic Colorectal Cancer. ACS Nano. 2024;18(34):23497\u2013507.","journal-title":"ACS Nano"},{"key":"4821_CR142","doi-asserted-by":"publisher","first-page":"120218","DOI":"10.1016\/j.biomaterials.2020.120218","volume":"257","author":"F Castro","year":"2020","unstructured":"Castro F, Pinto ML, Pereira CL, et al. Chitosan\/\u03b3-PGA nanoparticles-based immunotherapy as adjuvant to radiotherapy in breast cancer. Biomaterials. 2020;257:120218.","journal-title":"Biomaterials"},{"key":"4821_CR143","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijbiomac.2014.08.027","volume":"72","author":"JX Ma","year":"2015","unstructured":"Ma JX, Qian L, Zhou Y. Stimulation effect of chitosan on the immunity of radiotherapy patients suffered from lung cancer. Int J Biol Macromol. 2015;72:195\u20138.","journal-title":"Int J Biol Macromol"},{"key":"4821_CR144","doi-asserted-by":"publisher","unstructured":"Hussein MA, Hamdy AM, Abdelrhman IG, Auf M, Saifeldeen ER, Elashmony SM, Abuelkasem SS, Metwaly AM. Grafting of resveratrol-chitosan nanoparticles as a promising radiosensitizer and protector in DMBA-induced breast cancer in mice. Curr Cancer Drug Target. 2025. https:\/\/doi.org\/10.2174\/0115680096364549250828062651. Epub ahead of print. PMID: 40916413.","DOI":"10.2174\/0115680096364549250828062651"},{"issue":"2","key":"4821_CR145","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.canlet.2015.01.029","volume":"359","author":"F Zhou","year":"2015","unstructured":"Zhou F, Li X, Naylor MF, et al. InCVAX\u2013a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity. Cancer Lett. 2015;359(2):169\u201377.","journal-title":"Cancer Lett"},{"issue":"4","key":"4821_CR146","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1177\/1534735410387597","volume":"10","author":"X Li","year":"2011","unstructured":"Li X, Le H, Wolf RF, et al. Long-term effect on EMT6 tumors in mice induced by combination of laser immunotherapy and surgery. Integr Cancer Ther. 2011;10(4):368\u201373.","journal-title":"Integr Cancer Ther"},{"issue":"1","key":"4821_CR147","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1385\/MB:25:1:37","volume":"25","author":"WR Chen","year":"2003","unstructured":"Chen WR, Carubelli R, Liu H, Nordquist RE. Laser immunotherapy: a novel treatment modality for metastatic tumors. Mol Biotechnol. 2003;25(1):37\u201344.","journal-title":"Mol Biotechnol"},{"key":"4821_CR148","doi-asserted-by":"crossref","unstructured":"Chen WR, Huang Z, Korbelik M, Nordquist RE, Liu H. Photoimmunotherapy for cancer treatment. J Environ Pathol Toxicol Oncol. 2006. 25(1\u20132): 281\u2009\u2013\u200991.","DOI":"10.1615\/JEnvironPatholToxicolOncol.v25.i1-2.180"},{"key":"4821_CR149","doi-asserted-by":"publisher","first-page":"883428","DOI":"10.3389\/fphar.2022.883428","volume":"13","author":"J Wu","year":"2022","unstructured":"Wu J, Wang S, Liu S, Liu F, Zhou F. Immunoadjuvant Nanoparticles as Trojan Horses for Enhanced Photo-Immunotherapy in the Treatment of Triple-Negative Breast Cancer. Front Pharmacol. 2022;13:883428.","journal-title":"Front Pharmacol"},{"key":"4821_CR150","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nano.2019.02.009","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Li X, Doughty A, et al. Phototherapy using immunologically modified carbon nanotubes to potentiate checkpoint blockade for metastatic breast cancer. Nanomedicine. 2019;18:44\u201353.","journal-title":"Nanomedicine"},{"issue":"32","key":"4821_CR151","doi-asserted-by":"publisher","first-page":"e2402864","DOI":"10.1002\/adhm.202402864","volume":"13","author":"CH Hsiao","year":"2024","unstructured":"Hsiao CH, Lin YW, Liu CH, Nguyen HT, Chuang AE. Light-Driven Green-Fabricated Artificial Intelligence-Enabled Micro\/Nanorobots for Multimodal Phototherapeutic Management of Bladder Cancer. Adv Healthc Mater. 2024;13(32):e2402864.","journal-title":"Adv Healthc Mater"},{"key":"4821_CR152","doi-asserted-by":"publisher","first-page":"6137","DOI":"10.2147\/IJN.S429626","volume":"18","author":"W Tan","year":"2023","unstructured":"Tan W, Chen S, Xu Y, Chen M, Liao H, Niu C. Temperature-Sensitive Nanocarbon Hydrogel for Photothermal Therapy of Tumors. Int J Nanomed. 2023;18:6137\u201351.","journal-title":"Int J Nanomed"},{"key":"4821_CR153","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2147\/IJN.S432112","volume":"19","author":"Q Zhang","year":"2024","unstructured":"Zhang Q, Hu W, Guo M, et al. MMP-2 Responsive Peptide Hydrogel-Based Nanoplatform for Multimodal Tumor Therapy. Int J Nanomed. 2024;19:53\u201371.","journal-title":"Int J Nanomed"},{"issue":"2","key":"4821_CR154","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.apsb.2022.06.008","volume":"13","author":"J Cheng","year":"2023","unstructured":"Cheng J, Zhao H, Li B, et al. Photosensitive pro-drug nanoassemblies harboring a chemotherapeutic dormancy function potentiates cancer immunotherapy. Acta Pharm Sin B. 2023;13(2):879\u201396.","journal-title":"Acta Pharm Sin B"},{"key":"4821_CR155","doi-asserted-by":"publisher","first-page":"100532","DOI":"10.1016\/j.mtbio.2022.100532","volume":"18","author":"F Yu","year":"2023","unstructured":"Yu F, Shang X, Wang Z, et al. Drug-independent NADPH-consuming micelles collaborate with ROS-generator for cascade ferroptosis amplification by impairing redox homeostasis. Mater Today Bio. 2023;18:100532.","journal-title":"Mater Today Bio"},{"issue":"Pt A","key":"4821_CR156","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.ijbiomac.2022.09.245","volume":"222","author":"P Song","year":"2022","unstructured":"Song P, Lu Z, Jiang T, Han W, Chen X, Zhao X. Chitosan coated pH\/redox-responsive hyaluronic acid micelles for enhanced tumor targeted co-delivery of doxorubicin and siPD-L1. Int J Biol Macromol. 2022;222(Pt A):1078\u201391.","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"4821_CR157","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s11095-022-03297-9","volume":"39","author":"A Barshidi","year":"2022","unstructured":"Barshidi A, Karpisheh V, Noukabadi FK, et al. Dual Blockade of PD-1 and LAG3 Immune Checkpoints Increases Dendritic Cell Vaccine Mediated T Cell Responses in Breast Cancer Model. Pharm Res. 2022;39(8):1851\u201366.","journal-title":"Pharm Res"},{"key":"4821_CR158","doi-asserted-by":"publisher","first-page":"120166","DOI":"10.1016\/j.lfs.2021.120166","volume":"288","author":"F Karoon Kiani","year":"2022","unstructured":"Karoon Kiani F, Izadi S, Ansari Dezfouli E, et al. Simultaneous silencing of the A2aR and PD-1 immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine. Life Sci. 2022;288:120166.","journal-title":"Life Sci"},{"key":"4821_CR159","doi-asserted-by":"publisher","first-page":"108288","DOI":"10.1016\/j.intimp.2021.108288","volume":"101Pt A","author":"M Fathi","year":"2021","unstructured":"Fathi M, Bahmanpour S, Barshidi A, et al. Simultaneous blockade of TIGIT and HIF-1\u03b1 induces synergistic anti-tumor effect and decreases the growth and development of cancer cells. Int Immunopharmacol. 2021;101Pt A:108288.","journal-title":"Int Immunopharmacol"},{"key":"4821_CR160","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.actbio.2019.12.037","volume":"104","author":"P Yang","year":"2020","unstructured":"Yang P, Lu C, Qin W, et al. Construction of a core-shell microneedle system to achieve targeted co-delivery of checkpoint inhibitors for melanoma immunotherapy. Acta Biomater. 2020;104:147\u201357.","journal-title":"Acta Biomater"},{"issue":"29","key":"4821_CR161","doi-asserted-by":"publisher","first-page":"32259","DOI":"10.1021\/acsami.0c05090","volume":"12","author":"M Chen","year":"2020","unstructured":"Chen M, Quan G, Wen T, et al. Cold to Hot: Binary Cooperative Microneedle Array-Amplified Photoimmunotherapy for Eliciting Antitumor Immunity and the Abscopal Effect. ACS Appl Mater Interfaces. 2020;12(29):32259\u201369.","journal-title":"ACS Appl Mater Interfaces"},{"key":"4821_CR162","doi-asserted-by":"publisher","first-page":"123810","DOI":"10.1016\/j.ijpharm.2024.123810","volume":"652","author":"L Niu","year":"2024","unstructured":"Niu L, Liu Y, Li N, et al. Oral probiotics microgel plus Galunisertib reduced TGF-\u03b2 blockade resistance and enhanced anti-tumor immune responses in colorectal cancer. Int J Pharm. 2024;652:123810.","journal-title":"Int J Pharm"},{"key":"4821_CR163","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.carbpol.2014.04.102","volume":"111","author":"S Masuda","year":"2014","unstructured":"Masuda S, Azuma K, Kurozumi S, et al. Anti-tumor properties of orally administered glucosamine and N-acetyl-D-glucosamine oligomers in a mouse model. Carbohydr Polym. 2014;111:783\u20137.","journal-title":"Carbohydr Polym"},{"key":"4821_CR164","doi-asserted-by":"publisher","first-page":"173673","DOI":"10.1016\/j.ejphar.2020.173673","volume":"891","author":"Z Jiang","year":"2021","unstructured":"Jiang Z, Chi J, Li H, Wang Y, Liu W, Han B. Effect of chitosan oligosaccharide-conjugated selenium on improving immune function and blocking gastric cancer growth. Eur J Pharmacol. 2021;891:173673.","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"4821_CR165","doi-asserted-by":"publisher","first-page":"4977","DOI":"10.1016\/j.apsb.2024.09.015","volume":"14","author":"M Niu","year":"2024","unstructured":"Niu M, Pei Y, Jin T, et al. Colon-specific controlled release of oral liposomes for enhanced chemo-immunotherapy against colorectal cancer. Acta Pharm Sin B. 2024;14(11):4977\u201393.","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"4821_CR166","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1016\/j.apsb.2024.04.028","volume":"14","author":"C Yan","year":"2024","unstructured":"Yan C, Lv H, Feng Y, Li Y, Zhao Z. Inhalable nanoparticles with enhanced cuproptosis and cGAS-STING activation for synergistic lung metastasis immunotherapy. Acta Pharm Sin B. 2024;14(8):3697\u2013710.","journal-title":"Acta Pharm Sin B"},{"key":"4821_CR167","doi-asserted-by":"publisher","first-page":"109459","DOI":"10.1016\/j.carres.2025.109459","volume":"552","author":"G Zhu","year":"2025","unstructured":"Zhu G, Ruan Q, Tian Z, Liu F, Guo L, Zhang Z. Chitosan-based fluorescent nanocarriers: A novel drug delivery strategy for oral squamous cell carcinoma therapy. Carbohydr Res. 2025;552:109459.","journal-title":"Carbohydr Res"},{"key":"4821_CR168","doi-asserted-by":"publisher","first-page":"121422","DOI":"10.1016\/j.biomaterials.2022.121422","volume":"283","author":"G Li","year":"2022","unstructured":"Li G, Tao T, Deng D, et al. Collagen-targeted tumor-specific transepithelial penetration enhancer mediated intravesical chemoimmunotherapy for non-muscle-invasive bladder cancer. Biomaterials. 2022;283:121422.","journal-title":"Biomaterials"},{"key":"4821_CR169","doi-asserted-by":"publisher","first-page":"12957","DOI":"10.2147\/IJN.S487313","volume":"19","author":"H Li","year":"2024","unstructured":"Li H, Cui J, Zhang T, Lin F, Zhang G, Feng Z. Research Progress on Chitosan Microneedle Arrays in Transdermal Drug Delivery. Int J Nanomed. 2024;19:12957\u201373.","journal-title":"Int J Nanomed"},{"issue":"2","key":"4821_CR170","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/md8020292","volume":"8","author":"RA Muzzarelli","year":"2010","unstructured":"Muzzarelli RA. Chitins and chitosans as immunoadjuvants and non-allergenic drug carriers. Mar Drugs. 2010;8(2):292\u2013312.","journal-title":"Mar Drugs"},{"issue":"9","key":"4821_CR171","doi-asserted-by":"publisher","first-page":"1902938","DOI":"10.1002\/advs.201902938","volume":"7","author":"X Yao","year":"2020","unstructured":"Yao X, Jovevski JJ, Todd MF, et al. Nanoparticle-Mediated Intracellular Protection of Natural Killer Cells Avoids Cryoinjury and Retains Potent Antitumor Functions. Adv Sci (Weinh). 2020;7(9):1902938.","journal-title":"Adv Sci (Weinh)"},{"key":"4821_CR172","doi-asserted-by":"publisher","first-page":"108875","DOI":"10.1016\/j.carres.2023.108875","volume":"530","author":"S Bai","year":"2023","unstructured":"Bai S, Gao H, Tan LT, Yao L, Meng X, Zhang Y. A synthetic Tn-BSA conjugate vaccine bearing chitotriose as built-in adjuvant. Carbohydr Res. 2023;530:108875.","journal-title":"Carbohydr Res"},{"issue":"4","key":"4821_CR173","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1021\/acsbiomaterials.4c02036","volume":"11","author":"N Dalal","year":"2025","unstructured":"Dalal N, Dhandapani H, Ingle A, Sharma D, Tayalia P. Functionalized Poly(ethylene Glycol) Diacrylate Scaffolds for In Situ Immunomodulation of Dendritic Cells Targeting Melanoma Tumor. ACS Biomater Sci Eng. 2025;11(4):2396\u2013407.","journal-title":"ACS Biomater Sci Eng"},{"key":"4821_CR174","doi-asserted-by":"publisher","first-page":"115826","DOI":"10.1016\/j.biopha.2023.115826","volume":"168","author":"Y Jia","year":"2023","unstructured":"Jia Y, Taledaohan A, Jia R, et al. Chitosan nanomedicine containing RGD peptide and PAD4 inhibitor based on phenyl boronate coupling inhibition of primary tumor growth and lung metastasis. Biomed Pharmacother. 2023;168:115826.","journal-title":"Biomed Pharmacother"},{"key":"4821_CR175","doi-asserted-by":"publisher","first-page":"113957","DOI":"10.1016\/j.jconrel.2025.113957","volume":"384","author":"M Kong","year":"2025","unstructured":"Kong M, Qiu L. Coordinated modulation of glucose metabolism and immunity via metal-drug nanovesicles for hepatocellular carcinoma therapy. J Control Release. 2025;384:113957.","journal-title":"J Control Release"},{"key":"4821_CR176","doi-asserted-by":"publisher","first-page":"1118781","DOI":"10.3389\/fimmu.2023.1118781","volume":"14","author":"J Qian","year":"2023","unstructured":"Qian J, Yu X, Liu Z, et al. SRA inhibition improves antitumor potency of antigen-targeted chaperone vaccine. Front Immunol. 2023;14:1118781.","journal-title":"Front Immunol"},{"key":"4821_CR177","doi-asserted-by":"publisher","first-page":"124488","DOI":"10.1016\/j.ijbiomac.2023.124488","volume":"240","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Ling J, Xu X, Ouyang XK, Wang N. Redox and pH dual sensitive carboxymethyl chitosan functionalized polydopamine nanoparticles loaded with doxorubicin for tumor chemo-photothermal therapy. Int J Biol Macromol. 2023;240:124488.","journal-title":"Int J Biol Macromol"},{"issue":"42","key":"4821_CR178","doi-asserted-by":"publisher","first-page":"e2203466","DOI":"10.1002\/smll.202203466","volume":"18","author":"Y Cao","year":"2022","unstructured":"Cao Y, Liu S, Ma Y, et al. Oral Nanomotor-Enabled Mucus Traverse and Tumor Penetration for Targeted Chemo-Sono-Immunotherapy against Colon Cancer. Small. 2022;18(42):e2203466.","journal-title":"Small"},{"key":"4821_CR179","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carbpol.2015.04.040","volume":"129","author":"Z Jiang","year":"2015","unstructured":"Jiang Z, Han B, Li H, Yang Y, Liu W. Carboxymethyl chitosan represses tumor angiogenesis in vitro and in vivo. Carbohydr Polym. 2015;129:1\u20138.","journal-title":"Carbohydr Polym"},{"key":"4821_CR180","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.ijbiomac.2020.07.137","volume":"164","author":"E Amirani","year":"2020","unstructured":"Amirani E, Hallajzadeh J, Asemi Z, Mansournia MA, Yousefi B. Effects of chitosan and oligochitosans on the phosphatidylinositol 3-kinase-AKT pathway in cancer therapy. Int J Biol Macromol. 2020;164:456\u201367.","journal-title":"Int J Biol Macromol"},{"key":"4821_CR181","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijbiomac.2013.09.038","volume":"62","author":"YX Mei","year":"2013","unstructured":"Mei YX, Chen HX, Zhang J, Zhang XD, Liang YX. Protective effect of chitooligosaccharides against cyclophosphamide-induced immunosuppression in mice. Int J Biol Macromol. 2013;62:330\u20135.","journal-title":"Int J Biol Macromol"},{"key":"4821_CR182","doi-asserted-by":"publisher","first-page":"108008","DOI":"10.1016\/j.intimp.2021.108008","volume":"99","author":"HY Ji","year":"2021","unstructured":"Ji HY, Liu C, Dai KY, Yu J, Liu AJ, Chen YF. The immunosuppressive effects of low molecular weight chitosan on thymopentin-activated mice bearing H22 solid tumors. Int Immunopharmacol. 2021;99:108008.","journal-title":"Int Immunopharmacol"},{"key":"4821_CR183","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jconrel.2020.06.017","volume":"326","author":"M Esmaily","year":"2020","unstructured":"Esmaily M, Masjedi A, Hallaj S, et al. Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine. J Control Release. 2020;326:63\u201374.","journal-title":"J Control Release"},{"issue":"12","key":"4821_CR184","doi-asserted-by":"publisher","first-page":"10068","DOI":"10.1002\/jcp.29822","volume":"235","author":"M Ghasemi-Chaleshtari","year":"2020","unstructured":"Ghasemi-Chaleshtari M, Kiaie SH, Irandoust M, et al. Concomitant blockade of A2AR and CTLA-4 by siRNA-loaded polyethylene glycol-chitosan-alginate nanoparticles synergistically enhances antitumor T-cell responses. J Cell Physiol. 2020;235(12):10068\u201380.","journal-title":"J Cell Physiol"},{"key":"4821_CR185","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.ijbiomac.2021.07.034","volume":"186","author":"AM Salehi Khesht","year":"2021","unstructured":"Salehi Khesht AM, Karpisheh V, Sahami Gilan P, et al. Blockade of CD73 using siRNA loaded chitosan lactate nanoparticles functionalized with TAT-hyaluronate enhances doxorubicin mediated cytotoxicity in cancer cells. Int J Biol Macromol. 2021;186:849\u201363.","journal-title":"Int J Biol Macromol"},{"issue":"2","key":"4821_CR186","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11095-022-03169-2","volume":"39","author":"A Kheshti","year":"2022","unstructured":"Kheshti A, Hajizadeh F, Barshidi A, et al. Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response. Pharm Res. 2022;39(2):353\u201367.","journal-title":"Pharm Res"},{"key":"4821_CR187","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejpb.2020.08.013","volume":"155","author":"A Mohabati Mobarez","year":"2020","unstructured":"Mohabati Mobarez A, Soleimani N, Esmaeili SA, Farhangi B. Nanoparticle-based immunotherapy of breast cancer using recombinant Helicobacter pylori proteins. Eur J Pharm Biopharm. 2020;155:69\u201376.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"4821_CR188","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1080\/1061186X.2024.2344495","volume":"32","author":"R Zou","year":"2024","unstructured":"Zou R, Hao Y, Qi C, et al. Trimethyl chitosan-cysteine-based nanoparticles as an effective delivery system for portulacerebroside A in the management of hepatocellular carcinoma cells in vitro and in vivo. J Drug Target. 2024;32(5):570\u201384.","journal-title":"J Drug Target"},{"key":"4821_CR189","doi-asserted-by":"publisher","first-page":"116270","DOI":"10.1016\/j.carbpol.2020.116270","volume":"240","author":"X Yang","year":"2020","unstructured":"Yang X, Yu T, Zeng Y, et al. Tumor-draining lymph node targeting chitosan micelles as antigen-capturing adjuvants for personalized immunotherapy. Carbohydr Polym. 2020;240:116270.","journal-title":"Carbohydr Polym"},{"issue":"8","key":"4821_CR190","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1039\/D0BM01705A","volume":"9","author":"A Chauhan","year":"2021","unstructured":"Chauhan A, Midha S, Kumar R, et al. Rapid tumor inhibition via magnetic hyperthermia regulated by caspase 3 with time-dependent clearance of iron oxide nanoparticles. Biomater Sci. 2021;9(8):2972\u201390.","journal-title":"Biomater Sci"},{"issue":"7","key":"4821_CR191","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1021\/acs.biomac.0c00518","volume":"21","author":"X Yang","year":"2020","unstructured":"Yang X, Yu T, Zeng Y, et al. pH-Responsive Biomimetic Polymeric Micelles as Lymph Node-Targeting Vaccines for Enhanced Antitumor Immune Responses. Biomacromolecules. 2020;21(7):2818\u201328.","journal-title":"Biomacromolecules"},{"key":"4821_CR192","doi-asserted-by":"publisher","first-page":"118556","DOI":"10.1016\/j.carbpol.2021.118556","volume":"273","author":"X Li","year":"2021","unstructured":"Li X, Yu M, Zhu Z, et al. Oral delivery of infliximab using nano-in-microparticles for the treatment of inflammatory bowel disease. Carbohydr Polym. 2021;273:118556.","journal-title":"Carbohydr Polym"},{"issue":"8","key":"4821_CR193","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.fct.2009.04.044","volume":"47","author":"KT Shen","year":"2009","unstructured":"Shen KT, Chen MH, Chan HY, Jeng JH, Wang YJ. Inhibitory effects of chitooligosaccharides on tumor growth and metastasis. Food Chem Toxicol. 2009;47(8):1864\u201371.","journal-title":"Food Chem Toxicol"},{"key":"4821_CR194","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.etap.2016.06.013","volume":"45","author":"S Hong","year":"2016","unstructured":"Hong S, Ngo DN, Kim MM. Inhibitory effect of aminoethyl-chitooligosaccharides on invasion of human fibrosarcoma cells. Environ Toxicol Pharmacol. 2016;45:309\u201314.","journal-title":"Environ Toxicol Pharmacol"},{"issue":"16","key":"4821_CR195","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2174\/156802609789909795","volume":"9","author":"H Yin","year":"2009","unstructured":"Yin H, Du Y, Zhang J. Low molecular weight and oligomeric chitosans and their bioactivities. Curr Top Med Chem. 2009;9(16):1546\u201359.","journal-title":"Curr Top Med Chem"},{"key":"4821_CR196","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.ijbiomac.2019.03.223","volume":"133","author":"A Masjedi","year":"2019","unstructured":"Masjedi A, Hassannia H, Atyabi F, et al. Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA\/CREB signaling pathway. Int J Biol Macromol. 2019;133:436\u201345.","journal-title":"Int J Biol Macromol"},{"key":"4821_CR197","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.biomaterials.2018.09.017","volume":"185","author":"Y Song","year":"2018","unstructured":"Song Y, Tang C, Yin C. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells. Biomaterials. 2018;185:117\u201332.","journal-title":"Biomaterials"},{"issue":"3","key":"4821_CR198","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.jconrel.2013.03.030","volume":"169","author":"OJ Kwon","year":"2013","unstructured":"Kwon OJ, Kang E, Choi JW, Kim SW, Yun CO. Therapeutic targeting of chitosan-PEG-folate-complexed oncolytic adenovirus for active and systemic cancer gene therapy. J Control Release. 2013;169(3):257\u201365.","journal-title":"J Control Release"},{"issue":"1","key":"4821_CR199","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/mnfr.201400412","volume":"59","author":"TS Vo","year":"2015","unstructured":"Vo TS, Ngo DH, Kang KH, Jung WK, Kim SK. The beneficial properties of marine polysaccharides in alleviation of allergic responses. Mol Nutr Food Res. 2015;59(1):129\u201338.","journal-title":"Mol Nutr Food Res"},{"issue":"Pt 1","key":"4821_CR200","doi-asserted-by":"publisher","first-page":"114303","DOI":"10.1016\/j.jconrel.2025.114303","volume":"388","author":"N Fan","year":"2025","unstructured":"Fan N, Zhang Y, Ge Z, et al. A safe saponin-based nano-strategy for manganese-mediated STING activation. J Control Release. 2025;388(Pt 1):114303.","journal-title":"J Control Release"},{"issue":"6","key":"4821_CR201","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1016\/j.apsb.2021.10.019","volume":"12","author":"J Zhao","year":"2022","unstructured":"Zhao J, Huang H, Zhao J, et al. A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy. Acta Pharm Sin B. 2022;12(6):2683\u201394.","journal-title":"Acta Pharm Sin B"},{"issue":"29","key":"4821_CR202","doi-asserted-by":"publisher","first-page":"13934","DOI":"10.1039\/C9NR03374B","volume":"11","author":"T Wang","year":"2019","unstructured":"Wang T, Zhang J, Hou T, Yin X, Zhang N. Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy. Nanoscale. 2019;11(29):13934\u201346.","journal-title":"Nanoscale"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04821-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04821-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04821-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:02:13Z","timestamp":1788454933000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04821-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":202,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4821"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04821-4","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Human ethics and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this manuscript, the authors used AI-based language assistance tools to support literature organization and language refinement of selected passages. All AI-assisted output was carefully reviewed, fact-checked against the cited primary literature, and edited by the authors, who take full responsibility for the accuracy, integrity, and originality of the content of this review. No AI tool is listed as an author, and no AI-generated content has been included without human verification.","order":3,"name":"Ethics","label":"Statement on the use of AI-based tools","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"831"}}